| At a glance | Highly contagious paramyxovirus with prodromal cough/coryza/conjunctivitis and Koplik spots, followed by cephalocaudal maculopapular rash; vaccine-preventable. | Mild togavirus rash illness in children and adults but devastating to the fetus when contracted in the first trimester (congenital rubella syndrome). |
|---|
| Classic presentation | Three Cs + Koplik spots + cephalocaudal rash in an unvaccinated child.; Prodrome (3-5 days): high fever (often 40 °C), cough, coryza, conjunctivitis (the three Cs), malaise; Koplik spots: 1-2 mm bluish-white papules on a red base on buccal mucosa opposite molars, 1-2 days before rash; Rash: erythematous maculopapular eruption beginning… | Mild pink rash with posterior auricular and suboccipital adenopathy in a postpubertal woman with new joint pain.; Prodrome (often absent in children): low-grade fever, malaise, mild coryza, sore throat 1-5 days before rash; Tender lymphadenopathy: posterior auricular, suboccipital, posterior cervical (hallmark); Rash: pink to light-red… |
|---|
| Workup / key labs | Clinical case definition (fever, generalized maculopapular rash ≥3 days, plus cough/coryza/conjunctivitis) confirmed by IgM positive or RT-PCR positive.; Measles-specific IgM and IgG (acute and convalescent); RT-PCR on nasopharyngeal swab, throat swab, urine, or blood — most sensitive within the first 5 days; Report immediately to… | Clinical syndrome plus positive IgM or RT-PCR. Congenital rubella: rubella-specific IgM in the infant, positive viral isolation, RT-PCR, or persistent rubella-specific IgG beyond expected maternal antibody decline.; Rubella IgM and IgG (paired sera) — IgM positive in acute infection; RT-PCR on nasopharyngeal or oral swab; Rubella IgG… |
|---|
| Imaging | Chest x-ray if pneumonia suspected | Fetal ultrasound for suspected congenital rubella with growth restriction, microcephaly, cardiac defects; Postnatal echocardiography in infants with suspected CRS (PDA, peripheral pulmonary stenosis) |
|---|
| First-line treatment | Supportive care: antipyretics, hydration, isolation (airborne precautions for 4 days after rash onset); Vitamin A: 200,000 IU PO on days 1 and 2 (50,000 IU if <6 months, 100,000 IU if 6-11 months) — WHO/AAP recommend for all children with measles; reduces mortality and ocular complications; Post-exposure prophylaxis: MMR vaccine within… | Supportive: antipyretics, NSAIDs for arthralgia; Droplet precautions for 7 days after rash onset; MMR vaccine (live, 2-dose schedule) — first dose 12-15 months, second 4-6 years; women of childbearing age should be screened and vaccinated postpartum if non-immune; MMR is contraindicated in pregnancy and should be avoided for 28 days… |
|---|